Thomas Michael Menino Convention & Exhibition Center,
Boston, US
From innovation to impact: understand leading and emerging obesity therapeutics that are transforming lives and reshaping global wellness
partneringONE is Now Live | Register Today and Start Scheduling 1-1s
Book your ticket today and gain access to partneringONE, allowing you to view the attendee list and pre-schedule meetings with all attendees of Obesity Science & Innovation, as well as all attendees of the co-located LSX World Congress USA.
PartneringONE is live. 1000+ leaders. One ticket.
The conversations that move the obesity market forward? They’re already happening.
With partneringONE now live, early-movers are locking in meetings with decision-makers across biotech, pharma, and investment — all converging at Obesity Science & Innovation.
Skip the small talk. Register now and connect directly with 1000+ leaders shaping the future of metabolic health.
Already registered? Visit our Partnering page for more information.
Focused Discussions to Drive Obesity Science & Innovation
+
Attendees
+
Expert Speakers
+
Partnering Hours
Big Ideas Start with Great Conversations
GLP-1 CLINICAL HIGHLIGHTS
Exploring updates from leading GLP-1, dual- and tri-agonist clinical trials, across peptide and small molecule drug modalities.
ENERGY EXPENDITURE THERAPEUTICS
Discovering the latest approaches to modulate energy expenditure, including mitochondrial uncouplers and browning agents.
BIOLOGY & TRANSLATION
Diving into the complex biology of obesity, including the shaping of translational strategies to accelerate clinical development of therapeutics.
MAINTENANCE INNOVATION
Highlighting approaches to enhance patient adherence and weight-loss maintenance, including development of oral formulations and strategies for muscle mass retention.
BEYOND GLP-1 FRONTIERS
Showcasing next generation modalities and approaches in obesity therapeutics, hear from emerging early-stage innovators who are looking at solutions beyond GLP-1, such as inflammasome inhibitors, β2AR and cannabinoid receptor agonists
RNA & GENE THERAPY
Exploring gene therapy and RNA-based approaches for obesity, including siRNA, non-coding RNA and editing technologies.
Real Science. Real Innovation. Real Experts.
The speaker line-up features the game-changers in obesity science. From metabolic researchers to digital health pioneers, get direct access to the voices shaping tomorrow’s breakthroughs—today.
Every breakthrough begins with a conversation —science, tech, and networking all in one place
Explore the Newest Tech in Obesity Therapeutics
Connect with suppliers who will showcase the industry's latest technologies designed to accelerate obesity therapeutics towards commercial success.
Kick Back and Relax
Connect with industry colleagues during our networking breaks, lunches and our evening drinks reception.
Experience Our Partnering Platform
partneringONE is an online conference platform that allows delegates to contact other participants and schedule meetings with them. It can also be used as a simple networking and messaging tool.
Your Pass. Your Experience.
Obesity Science & Innovation drives the future of obesity therapeutics by bringing together the most innovative companies with the right partners.
Attend As A Delegate
Connect with new peers for two days of insightful presentations, expert panels, and networking opportunities with some of the brightest minds in obesity therapeutics.
Present Your Company
Take the opportunity to showcase your breakthroughs to an audience of potential partners and investors.
Join As An Investor
Qualified investors and research analysts are invited to request a complimentary registration to attend Obesity Science & Innovation.
Engage Qualified Decision-Makers Across the Obesity Therapeutics Landscape!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your sales and marketing goals.
To learn more about sponsorship opportunities, contact Roshni Shah: